Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of ZNF367 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 224.31 | 1423 / 1445 | 100% | 18.52 | 183 / 183 |
intestine | 98% | 188.78 | 948 / 966 | 98% | 13.64 | 518 / 527 |
stomach | 92% | 141.04 | 332 / 359 | 98% | 14.68 | 281 / 286 |
uterus | 95% | 117.75 | 162 / 170 | 95% | 21.96 | 436 / 459 |
breast | 98% | 137.15 | 449 / 459 | 92% | 11.43 | 1031 / 1118 |
skin | 98% | 389.88 | 1765 / 1809 | 91% | 11.37 | 430 / 472 |
ovary | 98% | 172.85 | 177 / 180 | 88% | 7.77 | 379 / 430 |
bladder | 100% | 138.52 | 21 / 21 | 86% | 10.12 | 435 / 504 |
lung | 99% | 221.85 | 572 / 578 | 85% | 9.39 | 987 / 1155 |
brain | 98% | 185.40 | 2599 / 2642 | 84% | 9.04 | 594 / 705 |
liver | 100% | 259.46 | 226 / 226 | 75% | 7.22 | 304 / 406 |
kidney | 100% | 180.97 | 89 / 89 | 69% | 5.14 | 619 / 901 |
thymus | 96% | 105.00 | 629 / 653 | 70% | 5.41 | 421 / 605 |
pancreas | 80% | 70.05 | 262 / 328 | 68% | 4.10 | 121 / 178 |
adrenal gland | 81% | 91.58 | 210 / 258 | 65% | 6.46 | 149 / 230 |
prostate | 90% | 89.93 | 221 / 245 | 36% | 1.96 | 179 / 502 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.47 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.68 | 1 / 1 |
spleen | 100% | 194.43 | 240 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 213.95 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 179.58 | 1190 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.63 | 28 / 29 |
muscle | 95% | 157.57 | 764 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 161.05 | 807 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 364.92 | 552 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 4.00 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF367 |
Protein name | Zinc finger protein 367 (C2H2 zinc finger protein ZFF29) |
Synonyms | ZFF29 |
Description | FUNCTION: Transcriptional activator. Isoform 1 may be involved in transcriptional activation of erythroid genes. . |
Accessions | ENST00000375256.5 [Q7RTV3-1] Q7RTV3 |